Filing Details
- Accession Number:
- 0001209191-21-055496
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-09-10 17:19:23
- Reporting Period:
- 2021-04-16
- Accepted Time:
- 2021-09-10 17:19:23
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1087294 | Cumberland Pharmaceuticals Inc | CPIX | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1075050 | J A Kazimi | 2525 West End Ave. Suite 950 Nashville TN 37203 | Chairman And Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-04-16 | 15 | $3.03 | 5,767,734 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-04-19 | 15 | $3.04 | 5,767,749 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-04-20 | 15 | $3.02 | 5,767,764 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-04-21 | 15 | $2.97 | 5,767,779 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-04-22 | 15 | $2.96 | 5,767,794 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-04-23 | 15 | $2.99 | 5,767,809 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-04-26 | 15 | $2.97 | 5,767,824 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-04-27 | 15 | $2.94 | 5,767,839 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-04-28 | 15 | $2.94 | 5,767,854 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-04-29 | 15 | $2.89 | 5,767,869 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-04-30 | 15 | $2.78 | 5,767,884 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-05-03 | 15 | $2.66 | 5,767,899 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-05-04 | 15 | $2.66 | 5,767,914 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-05-05 | 15 | $2.73 | 5,767,929 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-05-06 | 15 | $2.74 | 5,767,944 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-05-07 | 15 | $2.73 | 5,767,959 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-05-10 | 15 | $2.71 | 5,767,974 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-05-11 | 15 | $2.68 | 5,767,989 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-05-12 | 15 | $2.86 | 5,768,004 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-05-13 | 15 | $2.88 | 5,768,019 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-05-14 | 15 | $2.81 | 5,768,034 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-05-17 | 15 | $2.84 | 5,768,049 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-05-18 | 15 | $2.89 | 5,768,064 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-05-19 | 15 | $2.83 | 5,768,079 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-05-20 | 15 | $2.94 | 5,768,094 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-05-21 | 15 | $3.06 | 5,768,109 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-05-24 | 15 | $3.05 | 5,768,124 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-05-25 | 15 | $2.91 | 5,768,139 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-05-26 | 15 | $2.85 | 5,768,154 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-05-27 | 15 | $2.94 | 5,768,169 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.